Fact CheckerSign in

NCT05931783Recruiting

Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery

Randomized Comparison of HARVesting the Left Internal Thoracic Artery in a Skeletonized Versus Pedicled Technique: the HARVITA Trial

Source: ClinicalTrials.gov · Last updated 15 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Internal thoracic arteries can be harvested in skeletonized or pedicled technique. Latest research has posed a potential adverse effect of skeletonizing the internal thoracic arteries on graft patency rates and clinical outcome. Prospective, randomized, multi-centre trials are necessary to investigate the impact of harvesting technique of left internal thoracic artery (LITA) on graft patency rates and clinical outcome after coronary artery bypass grafting. The HARVITA trial compares skeletonized and pedicled harvesting technique of LITA regarding graft patency rates and patient survival.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
1350 (estimated)
First submitted
22 Jun 2023
Start date
12 Mar 2024
Primary completion date
1 Oct 2028
Lead sponsor
Medical University Innsbruck
NCT number
NCT05931783

What you commit to

  • Study type: Interventional
  • Planned participants: 1350
  • From 12 Mar 2024 to the primary completion date, 1 Oct 2028
  • 8 sites in 3 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Preoperative mediastinal radiation therapy
  • Minimal invasive coronary artery bypass surgery
  • Any concomitant cardiac or non-cardiac procedures
  • Previous cardiac surgery

Other illness

  • Known contrast agent allergy
  • Severe stenosis of the left subclavian artery/ left-sided subclavian steal syndrome
  • Iodine allergy
    • Intraoperative exclusion criteria:

Lab values

  • Chronic kidney disease (GFR \<60ml/min/1.73m²)

Age

  • Age \> 80 years

Other

  • Planned CABG without LITA use
  • Emergency operation
  • Life expectancy of less than 5 years
  • Pregnancy
  • Hyperthyroidism
  • Y/T graft off the LITA graft
  • LITA sequential grafting
  • LITA target vessel other than LAD

Who the study is looking for

  • Primary isolated CABG patients with multi-vessel disease (defined as ≥70 % stenosis of the left anterior descending artery (LAD) and ≥50% stenosis of circumflex and right coronary territory, with or without a ≥50% stenosis of the left main artery).

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (8)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Medical University of Graz
Coordinator of this site? Confirm its status
GrazAustriaNot yet recruiting
Medical University of Innsbruck
Coordinator of this site? Confirm its status
InnsbruckAustriaRecruiting
Medical University of Vienna
Coordinator of this site? Confirm its status
ViennaAustriaNot yet recruiting
University Hospital Bern
Coordinator of this site? Confirm its status
BernSwitzerlandNot yet recruiting
University of Duisburg-Essen
Coordinator of this site? Confirm its status
EssenGermanyNot yet recruiting
University of Freiburg
Coordinator of this site? Confirm its status
Freiburg im BreisgauGermanyNot yet recruiting
University Hospital Gießen
Coordinator of this site? Confirm its status
GiessenGermanyNot yet recruiting
University of Jena
Coordinator of this site? Confirm its status
JenaGermanyNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.